ImmunityBio, Inc. — Director's Dealing 2016

May 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2016-05-13

Reporting Person: BLASZYK MICHAEL D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-13	Common Stock	A	50000	$0.00	Acquired	50000	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of NantKwest, Inc. common stock.

F2: Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: twenty five percent (25%) of the RSUs subject to the award shall vest on June 30, 2016, thereafter, twenty five percent (25%) of the RSUs subject to the award shall vest on June 30, 2017, and fifty percent (50%) of the RSUs subject to the award shall vest on June 30, 2019, such that the award shall be fully vested on June 30, 2019.